Target intelligence / Profile preview

Blue light and ultraviolet radiation

Molecular classification
Other
01

Overview

"Blue light and ultraviolet radiation" are not molecules or receptors but rather forms of electromagnetic radiation within specific wavelength ranges. **Blue light** typically refers to visible wavelengths between approximately 400–500 nm. **Ultraviolet (UV) radiation** is non-visible electromagnetic energy subdivided into UV-A (315–400 nm), UV-B (280–315 nm), and UV-C (<280 nm). These types of radiation act as environmental signals that are detected by specialized photoreceptor proteins in living organisms. In plants and animals, the biological effects of blue/UV light are mediated by dedicated photoreceptors such as cryptochromes and phototropins. Cryptochromes absorb both blue and some ultraviolet wavelengths; they play key roles in regulating circadian rhythms in animals[3], controlling growth responses in plants[1][2], mediating stress responses[1], and influencing developmental processes like flowering time[3]. In bacteria, similar flavin-based receptors exist for sensing these wavelengths[1]. Ultraviolet radiation can also directly cause DNA damage—especially at shorter wavelengths—leading to mutations that underlie diseases such as skin cancer. While "blue light/UV radiation" itself is not a therapeutic target or molecular entity suitable for drug targeting, the downstream signaling pathways activated by their respective photoreceptors may be considered targets for intervention. Because "blue light/UV radiation" does not refer to a single molecule or receptor but rather physical phenomena detected by various molecular sensors across species, it is not appropriate to classify it as a canonical therapeutic target. The correct approach would be to specify individual photoreceptor proteins such as "Cryptochrome 1," "Phototropin," or others depending on context[6][2][3].

Other names
Blue lightUltraviolet radiationUV radiationUV lightVisible blue spectrum
02

Biological functions

Regulation of circadian rhythmsPhotomorphogenesisDNA damage induction (UV)Signal transduction via photoreceptors
03

Disease associations

Cancer (UV-induced skin cancer)Other (e.g., photoaging, eye disorders)
04

Safety considerations

DNA damage and mutagenesis from UV exposureSkin cancer risk with excessive UV exposureEye injury or retinal damage from intense blue/UV light

Beyond the preview

Go deeper on Blue light and ultraviolet radiation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blue light and ultraviolet radiation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call